del Nido cardioplegia in surgery for aortic root disease: a historically controlled study.

BACKGROUND: To determine the safely and effectively of del Nido cardioplegia (DNC) in surgery for aortic root disease, with mild hypothermic cardiopulmonary bypass (CPB).
METHODS: From July to December 2017, all patients undergoing the surgery for aortic root disease (total aortic root replacement, valve-sparing aortic root replacement and replacement of aortic valve plus ascending aorta), with mild hypothermic CPB, were retrospectively reviewed at our institution. Patients were divided into two groups based on the type of cardioplegia: the classical blood cardioplegia (CBC group) and del Nido cardioplegia (DNC group). Demographics, operative details, perioperative data and postoperative complications were recorded and compared. A propensity score matching was performed in this study.
RESULTS: The preoperative data in DNC group were similar to CBC group. The volume of ultrafiltration was lower in DNC than CBC group (2,053.49±806.62 DNC vs. 2,666.00±967.14 CBC, P=0.001), when matched. The use of temporary pacemaker was more in DNC group (n=20, 46.5%, P=0.023), and the rate of automatic heart resuscitating was higher in the CBC group (92.0% vs. 72.1% DNC group, P=0.024, unmatched).There were no differences in in-hospital mortality, troponin T (mean 0.66 ng/mL for CBC group vs. 0.49 ng/mL for DNC group, P=0.152), left ventricular ejection fraction (mean 58.37% for CBC group vs. 60.07% for DNC group, P=0.395) or other postoperative complications between two groups, after matching. In subgroup analysis, the ultrafiltration volume was lower in DNC than CBC group (1,932.26±749.39 DNC vs. 2,640.00±996.24 CBC, P=0.004), when ACC time less than or equal to 90 minutes. The apache score was better in DNC group (4.75±3.41, P=0.041), when ACC time greater than 90 min. There were no statistical significances in other characteristics between groups.
CONCLUSIONS: DNC is safe and effective for surgery for aortic root disease, not inferior to the CBC. 2020 Journal of Thoracic Disease. All rights reserved.

Introduction

The topic of myocardial protection has been accompanied by the development of cardiac surgery for decades. In the development of myocardial protection research and clinical practice, a series of milestones have been achieved, such as hypothermia, high potassium depolarization arrest, ventricular drainage, St. Thomas crystalloid solution, 4:1 blood cardioplegia and multiple perfusion methods as the core of systematic Buckberg blood cardioplegia concept and Brettschneider solution (Custodial-HTK solution). At our institution, the classical blood cardioplegia (CBC) based on St. Thomas solution, referring to the basic principles of Buckberg (mixed with patient blood in a 1:4 ratio) has been used in adult cardiac surgery. However, this solution is repeated administered at 20–30 min thereafter, which may have interrupted the surgeon.

del Nido cardioplegia (DNC), as a hyperkalemia, non-calcium imitating extracellular fluid, has been well used in pediatric cardiac surgery for decades (1). In recent years, DNC (mix with patient blood in a 4:1 ratio) has attracted much attention in adult cardiac surgery, owing to single-dose, ease of administration, and less expense (2-4). It has been used in our center since May 2017, as an alternative (5). Meanwhile, this cardioplegia had been well accepted by our cardio-vascular surgical team. Although it has been reported that DNC has been successfully used in adult cardiac surgery at some heart centers (6-8). No clinical trial has tested whether DNC could safety and efficacy used in surgery for aortic root disease in adults, because of the longer heart arrested time than isolated cardiac valve surgery. Therefore, a historically controlled study was established to prove whether DNC could evaluate myocardial protection not inferior to CBC during primary surgery for aortic root disease, with mild hypothermic cardiopulmonary bypass (CPB). We present the following article in accordance with the STROBE reporting checklist (available at http://dx.doi.org/10.21037/jtd-20-1101).

Methods

Patient population

This study was a single-center, non-randomized, historically controlled trial. Between July and December 2017, a total of 93 consecutive patients underwent the aortic root surgery by the same team of surgeon at our institution, including total aortic root replacement (n=41), valve-sparing aortic root replacement (n=9) and aortic valve plus ascending aorta replacement (n=43), without deep hypothermic circulatory arrest. All patients were divided into two groups based on the type of cardioplegia solution: the CBC (CBC group, n=50) and del Nido cardioplegia (DNC group, n=43).

Operative details and cardioplegia

All patients were performed using standard intravenous inhalation-general anesthesia, median sternotomy approach, with mild hypothermia CPB (32 to 35 °C). Ice slush was covered on the heart to ensure that the right ventricle remained cold, when heart arrested. Intraoperative transesophageal echocardiography was routinely used. Left ventricular drainage was used in patients with severe aortic insufficiency. Myocardial protection was achieved with either CBC or DNC as follows ( for a comparison of cardioplegia solution composition). The decision about the cardioplegia used was made by surgeon. In both groups, the cold cardioplegia (4 °C) was delivered direct through left and right coronary artery, or aortic root with an induction dose (1 liter). In CBC group, the induction cardioplegia was administered with CBC No. 1. In addition, repeated doses of CBC were given CBC No. 2 via retrograde coronary sinus catheter or coronary artery at 20–30 min intervals in CBC group. In general, the CBC was based on St. Thomas solution, referring to the basic principles of Buckberg solution, with controlled terminal warm blood cardioplegia (hot shot) given before cross-clamp removal (approximately 300–400 mL) (3). In DNC group, repeated dose (300 mL) of DNC was given via coronary artery at 60 min intervals if the heart arrested expected over 90 minutes. When the proximal aortic anastomosis and coronary reimplantation were done, rapid antegrade cardioplegia was provided to ensure anastomotic absolute hemostasis, in both groups.

Table 1

Composition of classical blood cardioplegia vs. del Nido cardioplegia

	Classical blood cardioplegia No. 1	Classical blood cardioplegia No. 2	del Nido cardioplegia
Carrier	Plasma-lyte A 500 mL	Plasma-lyte A 500 mL	Plasma-lyte A 500 mL
Blood: crystalloid ratio	4:1	4: 1	1:4
10% Potassium chloride, mL	35	15	10
5% Sodium bicarbonate, mL	0	0	11
20% Mannitol, mL	0	0	8.15
25% Magnesium sulfate, mL	8	8	4
2% Lidocaine, mL	2.5	2.5	3.25
10% Calcium chloride, mL	3	3	0

Data

This study was conducted in accordance with the Declaration of Helsinki and the Harmonized Tripartite Guideline (as revised in 2013). This study was reviewed and approved by the Ethics Committee in Zhongshan Hospital of Fudan University (approval NO: 2017-120) and was conducted in full compliance with its policies and procedures. All patients enrolled completed the informed consent form. All data were retrieved from the Zhongshan Hospital Fudan University, and approved for use in research by the institutional review board.

The patients’ general information was retrospectively collected, including age, gender, body mass index (BMI), New York Heart Association (NYHA) symptom class, and comorbid medical conditions, including hypertension, smoking history, coronary heart disease (coronary artery occlusion 50–70%), diabetes, cerebrovascular disease, chronic obstructive pulmonary disease, and atrial fibrillation. The pre/post-operative echocardiographic data and variable laboratory inspection were documented, in which the postoperative blood samples was routinely obtained in the first day morning after surgery. The intra/post-operative details that were collected included the type of surgical procedure, CPB time, aortic cross-clamp (ACC) time, ultrafiltration volume, vasopressor/positive inotropic drugs after CPB, mechanical ventilation, ICU stay time, and postoperative in-hospital complications.

The primary outcome was postoperative measures of myocardial injury, included troponin T level (cTnT), creatine kinase (CKMB), left ventricular ejection fraction (LVEF), vasopressor/positive inotropic drugs after CPB, rate of automatic heart resuscitating and the use of temporary peacemaker. The second outcomes included in-hospital mortality, postoperative mechanical ventilation time, ICU stay, lactic acid peak value and renal insufficiency (blood urea nitrogen and creatinine taken in the first day morning after surgery). The tertiary outcomes included CPB time, ACC time, and other postoperative complications.

Statistical analysis

Median (interquartile range), mean (standard deviation) and frequencies (percentages) were summarized according to cardioplegia solution types for non-normal continuous, normal continuous and categorical variables. A propensity score matching was performed and the all variables listed in were included in a logistic regression model to estimate the propensity score. Nearest-neighbor matching without replacement was used and the width of caliper equaled to 0. Loosing caliper to get more matched samples. Matching of two groups was performed to the demographic characteristics. For all data, Chi-square tests or Fisher Exact Tests were used for comparison of categorical variables and Wilcoxon tests (t test) were used for non-normal (normal) continuous variables between the two groups (). A subset analysis with matched data were summarized according to cardioplegia solution types (DNC solution and CBC solution) and ACC time (more than 90 minutes and less than 90 minutes). All data were analyzed by R (version 3.5.3).

Table 2

Demographic and clinical characteristics of the patients

Variable	Unmatched				Matched
	CBC (n=50)	DNC (n=43)	P value		CBC (n=43)	DNC (n=43)	P value
Age [years, mean (SD)]	55.44 (13.31)	58.63 (12.09)	0.233		55.88 (12.97)	58.63 (12.09)	0.313
Male (n, %)	35 (70.0)	36 (83.7)	0.191		30 (69.8)	36 (83.7)	0.202
Height [cm, mean (SD)]	167.96 (6.22)	168.35 (5.77)	0.757		168.19 (6.37)	168.35 (5.77)	0.901
Weight [kg, mean (SD)]	67.55 (10.39)	65.02 (9.76)	0.232		67.01 (10.25)	65.02 (9.76)	0.359
BMI [kg/m2, mean (SD)]	23.93 (3.38)	22.93 (3.19)	0.147		23.69 (3.37)	22.93 (3.19)	0.288
Hypertension (n, %)	28 (56.0)	15 (34.9)	0.068		23 (53.5)	15 (34.9)	0.129
Smoking (n, %)	10 (20.0)	3 (7.0)	0.132		7 (16.3)	3 (7.0)	0.313
CHD (n, %)	2 (4.0)	4 (9.3)	0.539		2 (4.7)	4 (9.3)	0.672
Diabetes (n, %)	4 (8.0)	6 (14.0)	0.556		4 (9.3)	6 (14.0)	0.737
CVD (n, %)	1 (2.0)	1 (2.3)	1.000		1 (2.3)	1 (2.3)	1.000
COPD (n, %)	8 (16.0)	1 (2.3)	0.061		6 (14.0)	1 (2.3)	0.115
Arrhythmia (n, %)	1 (2.0)	2 (4.7)	0.894		1 (2.3)	2 (4.7)	1.000
NYHA (n, %)			0.988				1.000
I	2 (4.0)	2 (4.7)			2 (4.7)	2 (4.7)
II	20 (40.0)	17 (39.5)			17 (39.5)	17 (39.5)
III	28 (56.0)	24 (55.8)			24 (55.8)	24 (55.8)

CBC, classical blood cardioplegia; DNC, del Nido cardioplegia; BMI, body mass index; CHD, coronary heart disease; CVD, cerebrovascular disease; COPD, chronic obstructive pulmonary disease; NYHA, New York Heart Association.

Table 3

Preoperative characteristics

Variable	Unmatched				Matched
	CBC (n=50)	DNC (n=43)	P value		CBC (n=43)	DNC (n=43)	P value
LVEF [%, mean (SD)]	59.80 (8.79)	59.77 (8.55)	0.986		59.51 (9.27)	59.77 (8.55)	0.895
IVS/LVPW [mean (SD)]	1.07 (0.11)	1.07 (0.12)	0.971		1.07 (0.12)	1.07 (0.12)	0.986
LA [mm, mean (SD)]	39.92 (7.12)	41.60 (5.12)	0.200		40.26 (7.48)	41.60 (5.12)	0.332
LVEDD [mm, mean (SD)]	57.30 (9.52)	58.14 (10.17)	0.682		57.60 (9.49)	58.14 (10.17)	0.802
AR grade (n, %)			0.951				0.988
Non	6 (12.0)	4 (9.3)			4 (9.3)	4 (9.3)
Low	5 (10.0)	5 (11.6)			4 (9.3)	5 (11.6)
Medium	10 (20.0)	10 (23.3)			10 (23.3)	10 (23.3)
Severe	29 (58.0)	24 (55.8)			25 (58.1)	24 (55.8)
cTnT (ng/mL, mean (SD)]	0.01 (0.01)	0.02 (0.03)	0.055		0.01 (0.01)	0.02 (0.03)	0.092
BNP (pg/mL, mean (SD)]	737.85 (1169.26)	1140.42 (1804.46)	0.199		837.13 (1233.33)	1140.42 (1804.46)	0.365
HCT (%, mean (SD)]	41.22 (3.26)	41.60 (3.90)	0.614		41.01 (3.22)	41.60 (3.90)	0.451
Blood Glucose [mmol/L, mean (SD)]	4.99 (0.72)	5.04 (0.80)	0.746		5.02 (0.76)	5.04 (0.80)	0.934
Blood potassium [mmol/L, mean (SD)]	3.98 (0.38)	4.05 (0.41)	0.362		3.97 (0.39)	4.05 (0.41)	0.321
ALT (U/L, mean (SD)]	20.28 (14.02)	19.56 (12.28)	0.794		19.05 (11.26)	19.56 (12.28)	0.841
AST (U/L, mean (SD)]	19.48 (7.54)	19.79 (7.07)	0.839		18.91 (6.06)	19.79 (7.07)	0.535
BUN [mmol/L, mean (SD)]	5.61 (1.45)	6.45 (1.96)	0.019		5.73 (1.47)	6.45 (1.96)	0.056
Creatinine (μmol/L, mean (SD)]	72.72 (13.75)	81.51 (13.98)	0.003		74.00 (14.15)	81.51 (13.98)	0.015
LDH (U/L, mean (SD)]	192.76 (38.83)	197.19 (46.03)	0.616		192.58 (40.94)	197.19 (46.03)	0.625
CRP (mg/L, mean (SD)]	1.63 (3.07)	1.40 (2.80)	0.704		1.76 (3.28)	1.40 (2.80)	0.583
Oxygenation index [mmHg, mean (SD)]	432.10 (76.54)	405.58 (85.85)	0.119		425.33 (74.17)	405.58 (85.85)	0.257

CBC, classical blood cardioplegia; DNC, del Nido cardioplegia; LVEF, left ventricular ejection fraction; IVS/LVPW, interventricular septum/left ventricular posterior wall; LA, left atrial; LVEDD, left ventricular end diastolic diameter; AR, aortic regurgitation; cTnT, troponin T; BNP, B-type natriuretic peptide; HCT, hematocrit; ALT, glutamic pyruvic transaminase; AST, glutamic oxaloacetic transaminase; BUN, blood urea nitrogen; LDH, lactic dehydrogenase; CRP, c-response protein.

Table 4

Intraoperative characteristics

Variable	Unmatched				Matched
	CBC (n=50)	DNC (n=43)	P value		CBC (n=43)	DNC (n=43)	P value
CPB time [min, mean (SD)]	120.66 (31.38)	123.88 (40.45)	0.667		123.09 (31.97)	123.88 (40.45)	0.920
Aortic cross-clamp time [min, mean (SD)]	80.90 (27.21)	84.72 (32.84)	0.541		82.63 (27.85)	84.72 (32.84)	0.751
Ultrafiltration volume [mL, mean (SD)]	2,666.00 (967.14)	2,053.49 (806.62)	0.001		2616.28 (969.03)	2,053.49 (806.62)	0.004
Operation type (n, %)			0.082				0.040
Total aortic root replacement	21 (42.0)	20 (46.5)			19 (44.2)	20 (46.5)
Valve-sparing aortic root replacement	8 (16.0)	1 (2.3)			8 (18.6)	1 (2.3)
Aortic valve plus ascending aorta replacement	21 (42.0)	22 (51.2)			16 (37.2)	22 (51.2)
Rate of automatic heart resuscitating (n, %)	46 (92.0)	31 (72.1)	0.024		39 (90.7)	31 (72.1)	0.052
Cardiac resuscitation time [min, mean (SD)]	4.62 (4.02)	3.26 (2.97)	0.070		4.37 (3.80)	3.26 (2.97)	0.133
Temporary pacemaker (n, %)	11 (22.0)	20 (46.5)	0.023		9 (20.9)	20 (46.5)	0.023
Epinephrine after CPB [μg/kg/min, mean (SD)]	0.01 (0.04)	0.00 (0.01)	0.295		0.00 (0.01)	0.00 (0.01)	0.667
Noradrenaline after CPB [μg/kg/min, mean (SD)]	0.01 (0.01)	0.02 (0.03)	0.243		0.05 (0.12)	0.01 (0.01)	0.211
Dobutamine after CPB [μg/kg/min, mean (SD)]	1.39 (1.17)	1.63 (1.10)	0.436		1.10 (1.10)	1.52 (1.19)	0.324

CBC, classical blood cardioplegia; DNC, del Nido cardioplegia; CPB, cardiopulmonary bypass; cardiac resuscitation time, time from aortic opening to cardiac resuscitation.

Table 5

Postoperative characteristics at the first day after operation

Variable	Unmatched				Matched
	CBC (n=50)	DNC (n=43)	P value		CBC (n=43)	DNC (n=43)	P value
EuroSCORE II [mean (SD)]	3.24 (2.54)	3.21 (2.75)	0.955		3.37 (2.58)	3.21 (2.75)	0.778
Apache score [mean (SD)]	7.14 (3.12)	6.84 (3.62)	0.666		7.09 (3.05)	6.84 (3.62)	0.724
Mechanical ventilation time (n, %)			0.357				0.492
<24 h	39 (78.00)	32 (74.42)			35 (81.4)	32 (74.42)
≥24 and <48 h	9 (18.00)	6 (13.95)			6 (14.0)	6 (13.95)
≥48 h	2 (4.00)	5 (11.63)			2 (4.7)	5 (11.63)
ICU stay [hours, mean (SD)]	33.52 (26.04)	52.19 (75.10)	0.103		34.74 (27.41)	52.19 (75.10)	0.156
Hospitalization [days, mean (SD)]	8.72 (3.43)	8.88 (3.93)	0.831		8.93 (3.63)	8.88 (3.93)	0.955
Oxygenation index [mmHg, mean (SD)]	298.68 (126.58)	310.09 (95.55)	0.629		295.28 (130.53)	310.09 (95.55)	0.550
Lactic acid peak value [mmol/L, mean (SD)]	2.67 (1.19)	2.32 (0.90)	0.115		2.68 (1.27)	2.32 (0.90)	0.135
cTnT [ng/mL, mean (SD)]	0.61 (0.67)	0.49 (0.25)	0.263		0.66 (0.71)	0.49 (0.25)	0.152
BNP [pg/mL, mean (SD)]	484.49 (487.94)	740.86 (847.97)	0.072		523.85 (513.16)	740.86 (847.97)	0.155
CKMB [U/L mean (SD)]	35.90 (20.70)	32.07 (13.99)	0.307		36.95 (21.87)	32.07 (13.99)	0.221
ALT [U/L, mean (SD)]	22.04 (23.86)	17.02 (12.63)	0.219		20.77 (24.67)	17.02 (12.63)	0.378
AST [U/L, mean (SD)]	53.84 (44.41)	41.58 (15.67)	0.089		55.00 (47.55)	41.58 (15.67)	0.082
BUN [mmol/L, mean (SD)]	7.29 (1.80)	7.77 (1.93)	0.214		7.27 (1.76)	7.77 (1.93)	0.204
Creatinine [μmol/L, mean (SD)]	90.36 (30.89)	97.30 (18.63)	0.202		91.16 (29.72)	97.30 (18.63)	0.254
LDH [U/L, mean (SD)]	416.68 (134.39)	352.58 (71.92)	0.006		410.93 (136.29)	352.58 (71.92)	0.015
LVEF [%, mean (SD)]	59.00 (8.72)	60.07 (9.57)	0.574		58.37 (8.83)	60.07 (9.57)	0.395
LVEDD [mm, mean (SD)]	48.46 (5.98)	49.12 (7.05)	0.628		48.21 (6.14)	49.12 (7.05)	0.526
In-hospital mortality (n)	0	0	NA		0	0	NA
IABP support (n)	0	0	NA		0	0	NA
Hemodialysis (n)	0	0	NA		0	0	NA
Stroke (n, %)	0	0	0.409		0	2 (4.7)	0.474
Conscious disturbance (n, %)	1 (2.0)	0	1.000		1 (2.3)	0	1.000
Tracheotomy (n, %)	0	1 (2.3)	0.940		0	1 (2.3)	1.000

CBC, classical blood cardioplegia; DNC, del Nido cardioplegia; cTnT, troponin T; BNP, B-type natriuretic peptide; CKMB, creatine kinase, muscle b; ALT, glutamic pyruvic transaminase; AST, glutamic oxaloacetic transaminase; BUN, blood urea nitrogen; LDH, lactic dehydrogenase; LVEF, left ventricular ejection fraction; LVEDD, left ventricular end diastolic diameter; IABP, intra-aortic balloon pump.

Table 6

Intraoperative characteristics for subgroup analysis of aortic cross-clamp time

	Aortic cross-clamp time ≤90 min (n=56)				Aortic cross-clamp time >90 min (n=30)
	CBC (n=25)	DNC (n=31)	P value		CBC (n=18)	DNC (n=12)	P value
CPB time [mean (SD)]	105.88 (28.79)	106.23 (19.31)	0.957		147.00 (17.74)	169.50 (45.62)	0.068
Ultrafiltration volume [mL, mean (SD)]	2,640.00 (996.24)	1,932.26 (749.39)	0.004		2583.33 (957.48)	2366.67 (896.80)	0.539
Rate of automatic heart resuscitating (n, %)	22 (88.0)	22 (71.0)	0.224		17 (94.44)	9 (75.00)	0.324
Cardiac resuscitation time [min, mean (SD)]	4.66 (4.37)	3.13 (2.85)	0.120		3.97 (2.88)	3.58 (3.37)	0.738
Temporary pacemaker (n, %)	5 (20.0)	15 (48.4)	0.054		4 (22.22)	5 (41.67)	0.464
Epinephrine after CPB [μg/kg/min, mean (SD)]	0.01 (0.04)	0.00 (0.01)	0.295		0.00 (0.01)	0.00 (0.01)	0.667
Noradrenaline after CPB [μg/kg/min, mean (SD)]	0.01 (0.01)	0.02 (0.03)	0.243		0.05 (0.12)	0.01 (0.01)	0.211
Dobutamine after CPB [μg/kg/min, mean (SD)]	1.39 (1.17)	1.63 (1.10)	0.436		1.10 (1.10)	1.52 (1.19)	0.324

CBC, classical blood cardioplegia; DNC, del Nido cardioplegia; CPB, cardiopulmonary bypass; cardiac resuscitation time, time from aortic opening to cardiac resuscitation.

Table 7

Postoperative characteristics for subgroup analysis of aortic cross-clamp time

	Aortic cross-clamp ≤90 (n=56)				Aortic cross-clamp >90 (n=30)
	CBC (n=25)	DNC (n=31)	P value		CBC (n=18)	DNC (n=12)	P value
EuroSCORE II [mean (SD)]	3.44 (2.71)	3.10 (2.21)	0.604		3.28 (2.47)	3.50 (3.92)	0.850
Apache score [mean (SD)]	7.00 (3.24)	7.65 (3.41)	0.475		7.22 (2.86)	4.75 (3.41)	0.041
Mechanical ventilation time (n, %)			0.482				0.933
<24 h	22 (88.0)	24 (77.4)			13 (72.2)	8 (66.7)
≥24 h and <48 h	2 (8.0)	3 (9.7)			4 (22.2)	3 (25.0)
≥48 h	1 (4.0)	4 (12.9)			1 (5.6)	1 (8.3)
ICU stay (hours, mean (SD)]	31.80 (29.69)	56.71 (86.74)	0.176		38.83 (24.10)	40.50 (28.48)	0.864
Hospitalization (days, mean (SD)]	9.72 (4.09)	8.71 (4.12)	0.364		7.83 (2.62)	9.33 (3.50)	0.190
Oxygenation index [mean (SD)]	312.76 (148.25)	328.13 (96.14)	0.641		271.00 (99.95)	263.50 (79.78)	0.829
Lactic acid (mmol/L, mean (SD)]	2.49 (0.70)	2.24 (0.84)	0.231		2.93 (1.79)	2.52 (1.05)	0.483
cTnT (ng/mL, mean (SD)]	0.56 (0.38)	0.46 (0.24)	0.263		0.80 (1.00)	0.57 (0.25)	0.443
BNP (pg/mL, mean (SD)]	580.76 (592.56)	691.08 (844.26)	0.583		444.80 (378.80)	869.45 (881.22)	0.080
CKMB (U/L, mean (SD)]	33.72 (19.65)	31.71 (11.12)	0.631		41.44 (24.48)	33.00 (20.23)	0.331
ALT (U/L, mean (SD)]	17.36 (17.53)	17.84 (14.20)	0.910		25.50 (32.08)	14.92 (7.25)	0.273
AST (U/L, mean (SD)]	44.68 (20.89)	39.35 (14.51)	0.266		69.33 (67.79)	47.33 (17.70)	0.283
BUN (mmol/L, mean (SD)]	7.19 (1.45)	7.92 (2.02)	0.132		7.37 (2.16)	7.39 (1.69)	0.979
Creatinine (μmol/L, mean (SD)]	91.80 (32.55)	98.84 (17.70)	0.307		90.28 (26.16)	93.33 (21.16)	0.739
LDH (U/L, mean (SD)]	395.84 (102.02)	333.87 (50.94)	0.005		431.89 (174.35)	400.92 (95.57)	0.580
LVEF (%, mean (SD)]	59.08 (8.60)	61.87 (9.08)	0.247		57.39 (9.29)	55.42 (9.60)	0.578
LVEDD (mm, mean (SD)]	47.36 (6.27)	48.58 (7.53)	0.519		49.39 (5.91)	50.50 (5.68)	0.613
In-hospital mortality (n)	0	0	NA		0	0	NA
IABP support (n)	0	0	NA		0	0	NA
Hemodialysis (n)	0	0	NA		0	0	NA
Stroke (n, %)	0	2 (6.5)	0.569		0	0	NA
Conscious disturbance (n, %)	1 (4.0)	0	0.913		0	0	NA
Tracheotomy (n, %)	0	1 (3.2)	1.000		0	0	NA

CBC, classical blood cardioplegia; DNC, del Nido cardioplegia; cTnT, troponin T; BNP, B-type natriuretic peptide; CKMB, creatine kinase, muscle b; ALT, glutamic pyruvic transaminase; AST, glutamic oxaloacetic transaminase; BUN, blood urea nitrogen; LDH, lactic dehydrogenase; LVEF, left ventricular ejection fraction; LVEDD, left ventricular end diastolic diameter; IABP, intra-aortic balloon pump.

Results

Patient demographics and preoperative characteristics

Patient general situation, comorbid medical conditions, preoperative echocardiographic data and variable laboratory inspection are presented in . There were total 93 patients reviewed, 50 in the CBC group and 43 in the DNC group. 43 patients in CBC group were matched vs. 43 patients in DNC group. Compared the two groups, serum urea nitrogen and creatinine were lower in CBC group than DNC, before matching. After matching, serum creatinine was still significantly lower in CBC group vs. the DNC group (74±14.15 vs. 81.51±13.98 µmol/L, P=0.015). There were no significant differences between other clinical data across groups.

Intraoperative characteristics

There was no significant difference between groups regarding total CPB time, ACC time, the resumption of heart beat time and vasopressor/positive inotropic drugs after CPB. Operative variables are presented in . Out of the 93 patients, 50 patients received intermittent CBC (CBC group, 21 for total aortic root replacement, 8 for valve-sparing aortic root replacement and 21 for aortic valve plus ascending aorta replacement), and 43 patients received DNC (DNC group, 20 for total aortic root replacement, 1 for valve-sparing aortic root replacement and 22 for aortic valve plus ascending aorta replacement). After matching, there was statistical difference in operation type between the two group (P=0.040). The ultrafiltration volume was also significantly lower for DNC compared to CBC (2,053.49±806.62 DNC vs. 2,666.00±967.14 CBC, P=0.001), which was similar after matching (P=0.004). The rate of automatic heart resuscitating was higher in the CBC group vs. DNC group (92.0% vs. 72.1%, P=0.024), however, it did not make sense after matching (90.7% vs. 72.1%, P=0.052). The use of temporary pacemaker was higher in DNC group than CBC group (P=0.023), whether matched.

Postoperative outcomes

No patient died or required IABP support/hemodialysis in the perioperative period. Patient postoperative outcomes, laboratory examination, echocardiographic variables, and postoperative in-hospital complications are presented in . After matching, the measured postoperative cTnT level showed no significant difference among groups, although it was slightly higher in CDC group (mean ± SD, 0.66±0.71 ng/mL for CBC group vs. 0.49±0.25 ng/mL for DNC group, P=0.152). The distribution value of LVEF was similar for groups (mean ± SD, 58.37%±8.83% for CBC group vs. 60.07%±9.57% for DNC group, P=0.395). There were no significant differences in euro score, apache score, mechanical ventilation time, ICU stay time, hospitalization, lactic acid peak value, laboratory data, or end-diastolic diameter of left ventricle (LVEDd), during the study in CBC group versus DNC group. Although there was no difference in oxygenation index between groups at the first day after surgery, the oxygenation index was lower than per-operation. There was a trend towards lower B-type natriuretic peptide (BNP) in the CBC group (P=0.072, in matched group P=0.155). It was significantly lower of lactate dehydrogenase (LDH) in DNC group than CBC group (352.58±71.92 vs. 416.68±134.39, P=0.006, matched P=0.015). In the DNC group, two patients suffered from stroke (P=0.409) and one patient was tracheotomized (P=0.940). One patient developed conscious disturbance and finally on the mend, in CBC group (P=1.000).

Subgroup analysis of ACC time for intro/post-operative characteristics

Patient intro/post-operative variables, with matched data, were presented in and . The ultrafiltration volume was lower in DNC than CBC group (1,932.26±749.39 DNC vs. 2,640.00±996.24 CBC, P=0.004), when ACC less than or equal to 90 minutes. On the opposite, there was no difference between the two groups, when ACC time greater than 90 min. In addition, the apache score was better in DNC group (4.75±3.41, P=0.041), when ACC time greater than 90 min. There were no statistical significances in other characteristics between groups.

Discussion

In recent decades, cardiovascular surgery technology has made great progress. The importance of myocardial protection technology is self-evident because it not only provides static and bloodless field for surgeons, but also ensures the recovery of myocardial function after operation. In our center, the CBC was used in most adult cardiac surgery for decades, and it had achieved stable clinical results. However, this cardioplegia needed to be repeated every 20–30 minutes. Therefore, it might interrupt the operation and bring inconvenience to surgeons, especially for the critical and complicated patients.

DNC was developed by Dr. del Nido to address the needs of immature myocardium, because of the poor tolerance of myocardial ischemic in neonatal and pediatric cardiac surgery (1). This cardioplegia was a hyperkalemic, non-calcium with lidocaine, magnesium and mannitol additives and mixed with patient blood in a 4:1 ratio. Recently, reports had suggested that the intracellular calcium was overloaded and could lead to irreversible myocardial injury, after myocardial ischemia in mature myocardium, due to the decrease of ATP produced by aerobic metabolism, and weak function of Na+ channel Ca2+ channel, then a large amount of calcium in extracellular fluid moved into mitochondrion along the concentration difference (9-11). Consequently, mitochondrial damage and energy depletion impair myocardial contractile function (12). The concentration of Ca2+ in DN cardioplegia was significantly lower than that in CBC. It was theorized that the lidocaine content in DN could increase the blockade of Na+ channel, and the magnesium could competitive antagonist with Ca2+, thereby, decreasing the influx of Ca2+, preventing calcium overload (13-15). On the other side, the mannitol content in DN could alleviated the myocardial edema, and the sodium bicarbonate, acting as a buffer, could buffer the accumulation of H+ and alleviated the degree of acidosis, during ischemia (1,16). Recent reports had showed that DN cardioplegia had been successfully used in adult cardiac surgery in some centers (6-8). As a consequence, our center hypothesized that DN might have similar myocardial protection effects with CBC. Considering the different methods of cardioplegia perfusion, DN might have some advantages in the surgery for aortic root disease, compared with CBC (17). In this study, we found that DN cardioplegia offered equivalent postoperative outcomes compared to the CBC, regarding to cTnT and CKMB at post-operative day one, post-operative LVEF, vasopressor/positive inotropic drugs after CPB and rate of automatic heart resuscitating we monitored. Although, the use of temporary pacemaker in DNC group was higher than CBC group, we thought that it might because we used cardioplegia to test anastomotic hemostasis condition, when the proximal aortic anastomosis and coronary reimplantation were done. In this condition, the effect of DN was still obvious, and the heart was always soft and beat slowly, after we moved the cross-clamp. In addition, this condition would be better when patients were sent out of the operation room. Therefore, we thought that DN cardioplegia could provide safety myocardial protection, not inferior to classical cardioplegia we used before.

The post-operative ICU stay time for DNC group was higher than CBC group, although there was no statistical significance. We thought that it might because one patient in DNC group suffered from postoperative oxygenation dysfunction and underwent tracheotomy. But beyond that, DN cardioplegia provided similar to classical cardioplegia in mortality, postoperative mechanical ventilation time, and renal insufficiency. Consequently, we thought that DN cardioplegia was safe for aortic root surgery.

Although, DN cardioplegia was used as only one dose in majority cases, the optimal dosage and time limit had not been definitively established for adult, especially for patients with an ACC time greater than 90 minutes. In our previous study, single-dose DN cardioplegia was well used in adult minimally invasive valve surgery with ACC time less than 90 minutes (5). In this study, there were 30 patients had an ACC time greater than 90 minutes, and 12 patients belonged to the DNC group among them. Redosing was done in the 12 patients at 60 minutes and only 300 mL was given (left coronary 200 mL vs. right coronary 100 mL). In our series, only 2 patients in DNC group had an ACC time greater than 150 minutes (185, and 214 minutes). Therefore, the redosing was given at 60 minutes’ interval. Fortunately, there was no significantly difference in intro/post-operative characteristics between the two groups with ACC greater than 90 minutes, after matching. We considered that the volume of ultrafiltration was lower in DNC group might because that the total cardioplegia was less in DNC group. However, in this study, we failed to collect the total cardioplegia data. There was no difference in ACC time between DNC group and CBC group, but the advantage of DN cardioplegia was free from intermittent cardioplegia perfusion or retrograde perfusion, which could make the surgery process more smoothly.

The main limitation of our study is its retrospective, small sample size at a single institution. Long-term follow up outcome data were not performed. Finally, there were few patients underwent ACC time greater than 150 minutes, so we could not determine the optimal redosing dosage and time limit for the patients.

Conclusions

In this study, we concluded that the myocardial protection with DN cardioplegia is similar to the CBC, in patients underwent surgery for aortic root disease. In addition, the benefits of extending the redosing time and maintaining surgical continuity cannot be overlooked. For long aortic cross-clamping, it requires more validated studies to determine the optimal redosing dosage and time limit for patients.

The article’s supplementary files as